MSV
MRNA icon

MN Services Vermogensbeheer’s Moderna MRNA Stock Holding History

MN Services Vermogensbeheer’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-115,100
Closed -$3.26M – 490
2025
Q1 		$3.26M Sell
115,100
-9,100
-7% -$323K 0.03% 417
2024
Q4 		$5.16M Hold
124,200
– – 0.03% 381
2024
Q3 		$8.3M Sell
124,200
-3,100
-2% -$285K 0.06% 286
2024
Q2 		$15.1M Sell
127,300
-3,700
-3% -$468K 0.11% 178
2024
Q1 		$14M Sell
131,000
-23,400
-15% -$2.36M 0.1% 201
2023
Q4 		$15.4M Sell
154,400
-5,800
-4% -$488K 0.14% 184
2023
Q3 		$16.5M Buy
160,200
+4,000
+3% +$446K 0.16% 165
2023
Q2 		$19M Buy
+156,200
New +$20.8M 0.18% 149

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MN Services Vermogensbeheer's MRNA Position: Q2 2025 in Review

MN Services Vermogensbeheer sold out of Moderna (MRNA) in Q2 2025, closing a stake of 115,100 shares — an estimated $3.26M sold.

MN Services Vermogensbeheer first reported a position in MRNA in Q2 2023 and held it in 8 quarters. The position peaked at $19M in Q2 2023. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • MN Services Vermogensbeheer reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • MN Services Vermogensbeheer sold 115,100 Moderna shares in Q2 2025, an estimated $3.26M.
  • MN Services Vermogensbeheer first reported a position in Moderna in Q2 2023 and held it in 8 quarters.
  • MN Services Vermogensbeheer's Moderna position peaked at $19M in Q2 2023.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on MN Services Vermogensbeheer's 13F filing for Q2 2025, filed 10 Jul 2025.